Summary
Among the hospital infections, hospital-acquired central nervous system infections are quite important due to the high mortality. The pathogens that cause hospital-acquired meningitis differ according to the immune system and underlying diseases. The most frequent pathogens are gram-negative bacilli, Staphylococcus aureus, and coagulase-negative staphylococci. There are difficulties in the treatment due to the problem of increasing resistance. Treatment options of the multiple-drug-resistant pathogens are limited. In this paper, the treatment options of the hospital-acquired and methicillin-resistant S. aureus meningitis are reviewed.
References
1Arman D. Nozokomiyal santral sinir sistemi infeksiyonları ve şant infeksiyonları. Köksal İ, Çakar N, Arman D (editörler). Yoğun Bakım İnfeksiyonları. Ankara: Bilimsel Tıp Yayınevi, 2005: 197-222
2Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328: 21-8.
3Leib SL, Tauber MG. Acute and chronic meningitis. In: Cohen J, Powderly WG (eds). Infectious Diseases. 2nd ed. USA: Elseiver, 2003: 251-66.
4Weisfelt M, Van de Beek D, Spanjaard L, de Gans J. Nosocomial bacterial meningitis in adults: a prospective series of 50 cases. J Hosp Infect 2007; 66: 71-8.
5Palabiyikoglu I, Tekeli E, Cokca F, Akan O, Unal N, Erberktas I, Lale S, Kiraz S. Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect 2006; 62: 94-7.
6Sacar S, Turgut H, Toprak S, Cirak B, Coskun E, Yilmaz O, Tekin K. A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period. BMC Infect Dis 2006; 6: 43.
7Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis 1998; 17: 73-7.
8Van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med 2010; 362: 146-54.
9Ertem S. Akut bakteriyel menenjit: Etiyoloji ve epidemiyoloji. Eraksoy H, Yenen OS (editörler). İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji 2000. İstanbul: Nobel Tıp Kitabevi, 2000: 1-5.
10Yamazhan T, Arda B, Taşbakan M, Gökengin D, Ulusoy S, Serter D. Akut pürülan menenjitli 94 olgunun analizi. Klimik Dergisi 2004; 17: 95-8.
11Tunkel AR, Scheld WM. Acute meningitis. In: Bennett JE, Dolin R, Mandell GL (eds). Principles and Practice of Infectious Diseases. 7th ed. New York: Churchill Livingstone, 2010: 1189-230.
12Saba R, İnan D, Günseren F, Özçelik FT, Mamıkoğlu L. Akdeniz Üniversitesi Hastanesinde nozokomiyal menenjitler. Hastane İnfeksiyonları Dergisi 2000; 4: 47-50.
13Pintado V, Meseguer MA, Fortun J, Cobo J, Navas E, Quereda C, Corral I, Moreno S. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002; 21: 864-8.
14Arda B, Yamazhan T, Sipahi OR, İşlekel S, Buke C, Ulusoy S. Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases. Int J Antimicrob Agents 2005; 25: 414-8.
15Sipahi OR, Bardak S, Turhan T, Arda B, Pullukcu H, Ruksen M, Aydemir S, Dalbasti T, Yurtseven T, Zileli M, Ulusoy S. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases. Scand J Infect Dis 2011; 43: 757-64.
16Aguilar J, Urday-Cornejo V, Donabedian S, Perri M, Tibbetts R, Zervos M. Staphylococcus aureus meningitis: case series and literature review. Medicine (Baltimore) 2010; 89: 117-25.
17Wang KW, Chang WN, Huang CR, Tsai NW, Tsui HW, Wang HC, Su TM, Rau CS, Cheng BC, Chang CS, Chuang YC, Liliang PC, Tsai YD, Lu CH. Postneurosurgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci 2005; 12: 647-50.
18Dizbay M, Güzel TÖ. Nozokomiyal santral sinir sistemi infeksiyonlarında mortaliteyi etkileyen faktörler. ANKEM 2011; 25: 6-11.
19Naz H, Aykın N, Çağlan Çevik F. Hastane kökenli santral sinir sistemi infeksiyonları: 15 olgunun değerlendirilmesi. ANKEM 2009; 23: 82-5.
20Bulut C, Tekiner A, Yetkin MA, Hatipoğlu ÇA, Bayar MA, Tülek N. Beyin cerrahi girişimleri sonrası gelişen hastane kökenli menenjitlerin değerlendirilmesi. Hastane İnfeksiyonları Dergisi 2005; 9: 218-24.
21Erdem I, Hakan T, Ceran N, Metin F, Akcay SS, Kucukercan M, Berkman MZ, Goktas P. Clinical features, laboratory data management and the risk factors that affect the mortality in patients with postoperative meningitis. Neurol India 2008; 56: 433-7.
22Schlesinger LS, Ross SC, Schaberg DR. Staphylococcus aureus meningitis: a broad-based epidemiologic study. Medicine (Baltimore) 1987; 66: 148-56.
23Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt- Moller N. Staphylococcus aureus meningitis. A review bof 104 nationwide, consecutive cases. Arch Intern Med 1993; 153: 1902-8.
24Fong IW, Ranalli P. Staphylococcus aureus meningitis. QJM 1984; 53: 289-99.
25Kim JH, Van der Horst C, Mulrow CD, Corey GR. Staphylococcus aureus meningitis: review of 28 cases. Rev Infect Dis 1989; 11: 698-706.
26Gordon JJ, Harter DH, Phair JP. Meningitis due to Staphylococcus aureus. Am J Med 1985; 78: 965-9.
27Falco V, Almirante B, Pahissa A, Gasser I, Fernandez- Perez F, Martinez-Vazquez JM. Meningitis caused by Staphylococcus aureus. Analysis of 16 cases. Med Clin (Barc) 1990; 94: 208-11.
28Lerche A, Rasmussen N, Wandall JH, Bohr VA. Staphylococcus aureus meningitis: a review of 28 consecutive community-acquired cases. Scand J Infect Dis 1995; 27: 569-73.
29Pintado V, Pazos R, Jimenez-Mejías ME, Rodriguez- Guardado A, Gil A, García-Lechuz JM, Cabellos C, Chaves F, Domingo P, Ramos A, Perez-Cecilia E, Domingo D. Methicillin-resistant Staphylococcus aureus meningitis in adults: a multicenter study of 86 cases. Medicine (Baltimore) 2012; 91: 10-7.
30Huang WC, Lee CH, Liu JW. Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates. J Microbiol Immunol Infect 2010; 43: 470-7.
31Tülek N, Fışgın NT. Akut bakteriyel menenjitler. Topçu- Wilke A, Söyletir G, Doğanay M (editörler). Enfeksiyon Hastalıkları ve Mikrobiyolojisi. İstanbul: Nobel Tıp Kitabevleri, 2008: 1390-422.
32Greenlee JE, Carroll KC. Cerebrospinal fluid in central nervous system infections. In: Scheld WM, Whitley RJ, Marra CM (eds). Infections of the Central Nervous System. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2004: 5-30.
33The Sandford Guide to Antimicrobial Therapy. 41st ed. 2011: 79-84.
34Tunkel AR, Hartman BR. Practice guidelines for the management of bacterial meningitis. IDSA guidelines. Clin Infect Dis 2004; 39: 1267-84.
35Ulusoy S, Arda B. Dirençli stafilokok enfeksiyonları ve sağaltımı. Yüce A, Çakır N (editörler). Hastane Enfeksiyonları. İzmir: Güven Kitabevi, 2003: 49-65.
36Liu C, Bayer A. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: e18-55.
37Chaudhuri P, Martinez-Martin P, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, Steiner I; EFNS Task Force. EFNS guideline on the management of community- acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008; 15: 880.
38Sipahi OR, Arda B, Yurtseven T, Sipahi H, Özgiray E, Suntur BM, Ulusoy S. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant (MRSA). Int J Antimicrob Agents 2005; 26: 412-5.
39Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007; 41: 296-308.
40Sipahi O, Bardak-Ozcem S, Turhan T, Arda B, Ruksen M, Pullukcu H, Aydemir S, Dalbasti T, Yurtseven T, Sipahi H, Zileli M, Ulusoy S. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis: a retrospective cohort study. 22nd ed. London, United Kingdom: ECCMID 2012.
41Riser MS, Bland CM, Rudisill CN, Bookstaver PB. Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis. Ann Pharmacother 2010; 44: 1832-4.
42Cottagnoud P, Pfister M, Acosta F, Cottagnoud M, Flatz L, Kühn F, Müller HP, Stucki A. Daptomycin is highly efficacious against penicillin-resistant and penicillin-and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2004; 48: 3928-33.
43Kelesidis T, Humphries R, Ward K, Lewinski MA, Yang OO. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis 2011; 71: 286-90.
44Elvy J, Porter D, Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. J Antimicrob Chemother 2008; 61: 461-2.
45Jaspan HB, Brothers AW, Campbell AJ, McGuire JK, Browd SR, Manley TJ, Park D, Weissman SJ. Multidrugresistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 2010; 29: 379-81.
46Le J, Bookstaver PB, Rudisill CN, Hashem MG, Iqbal R, James CL, Sakoulas G. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high dose and combination daptomycin therapy. Ann Pharmacother 2010; 44: 2001-6.
47Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006; 57: 720-3
48Bardak-Ozcem S, Turhan T, Sipahi O, Arda B, Pullukcu H, Yamazhan T, Tasbakan M, Sipahi H, Ulusoy S. Daptomycin versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus meningitis in experimental rabbit model. 22nd ed. London, United Kingdom: ECCMID 31 March-3 April, 2012.
49Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, Paterson DL. Management of meningitis due to antibioticresistant Acinetobacter species. Lancet Infect Dis 2009; 9: 245-55.
50Altunçekiç A, Arman D. Acinetobacter cinsi bakterilerin mikrobiyolojisi, direnç mekanizmaları ve çoklu dirençli suşlarda tedavi. Arman D, Ünal S (editörler). Yeni ve Yeniden Gündeme Gelen İnfeksiyonlar. Ankara: Bilimsel Tıp Yayınevi, 2009: 123-36.
51Kendirli T, Aydín HI, Hacíhamdioğlu D, Gülgün M, Unay B, Akín R, Lenk MK, Gökçay E. Meningitis with multi drug resistant Acinetobacter baumannii treated with ampicillin/ sulbactam. J Hosp Infect 2004; 56: 328.
52Sipahi OR, Pullukçu H, Taşbakan M, Yamazhan T, Arda B, Dalbastı T, Turhan T, Aydemir Ş, Ulusoy S. Meropenem ile tedavi başarısızlığı sonrası ampisilin/sulbaktam ile başarılı bir şekilde tedavi edilen Acinetobacter baumannii menenjitli bir olgu. ANKEM 2006; 20: 236-8.
53Sayin Kutlu S, Saçar S, Süzer T, Cevahir N, Okke D, Dirgen Caylak S, Turgut H. Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam. Mikrobiyol Bul 2008; 42: 353-8.
54Ho YH, Wang LS, Chao HJ, Chang KC, Su CF. Successful treatment of meningitis caused by multi drug resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 2007; 40: 537-40.
55Jimenez-Mejías ME, Pichardo-Guerrero C, Marquez- Rivas FJ, Martín-Lozano D, Prados T, Pachon J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002; 21: 212-4
56Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007; 29: 9-25.
57Wadi JA, Rub MA, Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline. Ann Saudi Med 2007; 27: 456-8.
58Sipahi OR, Bardak S, Ozgiray E, Yurtseven T, Pullukcu H, Arda B, Ulusoy S. Multidrug resistant (MDR) Acinetobacter baumannii meningitis treated with tigecycline. 3rd ed. Eurasia Congress of Infectious Diseases. Baku, Azerbaijan, 2009.
59Fang G, Weiss W. Comparative efficacy of GAR-936 (GAR), a novel glycylcycline, alone and in combination wirh vancomycin against penicillin-resistant S. pneumoniae (PRPS) experimental meningitis in rabbits. 4th ed. İnterscience Conference on Antimicrobial Agents and Chemotheraphy 2000, Toronto, Canada.
60Yin LY, Lazzarini L, Li F. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 2005; 55: 995-1002.
61Buke C, Sipahi OR, Yurtseven T, Zileli M. High dose of intrathecal netilmicin in the treatment of nosocomial Acinetobacter baumannii meningitis. J Infect 2005; 51: 420-2.
